Scientists hunt for clues in colorectal cancer tissue and blood
NCT ID NCT01762813
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is gathering blood and tumor samples from 1,200 people with colorectal cancer who are having surgery to remove their cancer. Researchers want to look for biomarkers that might help predict how well patients do after surgery. The study does not test a new treatment, but aims to better understand the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help identify biomarkers that predict cancer recurrence or survival after surgery.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead to any direct benefit for participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Stavanger University Hospital
RECRUITINGStavanger, 4068, Norway
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a plasma beam stop colon polyps from coming back?
- A stitch in time: could a device make abdominal closure safer?
- Can we predict chemo brain before it happens?
- Your gut bacteria might reveal hidden cancer risk
- Can a smart digital program restore sleep for cancer survivors?
- Can a new infusion drug shrink Hard-to-Treat tumors?